The Relationship Between Red Cell Distribution Width and Cancer-Specific Survival in Patients With Renal Cell Carcinoma Treated With Partial and Radical Nephrectomy-Reference-Cited by-同舟云学术

The Relationship Between Red Cell Distribution Width and Cancer-Specific Survival in Patients With Renal Cell Carcinoma Treated With Partial and Radical Nephrectomy

Published:2018-06 Issue:3 Volume:16 Page:e677-e683
ISSN:1558-7673
Container-title:Clinical Genitourinary Cancer
language:en
Short-container-title:Clinical Genitourinary Cancer

Author:

Życzkowski Marcin,Rajwa Paweł,Gabrys Ewa,Jakubowska Karolina,Jantos Ewelina,Paradysz Andrzej

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference52 articles.

1. The epidemiology of renal cell carcinoma;Ljungberg;Eur Urol,2017

2. Cancer-related inflammation;Mantovani;Nature,2008

4. Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis;Templeton;J Natl Cancer Inst,2014

5. Comparison of the prognostic values of preoperative inflammation-based parameters in patients with breast cancer;Takeuchi;PLoS One,2017

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A red blood cell-based score in the prognostication of patients with metastatic RCC of the Meet-URO 15 study;Immunotherapy;2024-08-06

2. Clinical values of preoperative red blood cell distribution width and platelet parameters in patients with papillary thyroid carcinoma;Oncology Letters;2024-07-26

3. Preoperative Inflammation-Associated Blood Cell Markers in Patients with Non-Metastatic Clear Cell Renal Cell Carcinoma: A Retrospective Study;International Journal of General Medicine;2023-07

4. Does red blood cell distribution width predict prognosis in metastatic renal cell carcinoma patients using first-line vascular endothelial growth factor receptor tyrosine kinase inhibitor therapy?;Journal of Cancer Research and Therapeutics;2023

5. The role of mean corpuscular volume and red cell distribution width in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors: the MARECAP retrospective study;Therapeutic Advances in Urology;2023-01